The investigator site payment model has not fundamentally evolved since paper-based clinical trials. Today, it is a source of capital waste, operational friction, and systemic risk to the clinical research enterprise.
The payment latency problem is not marginal. It is structural and measurable at every layer of the clinical trial financial stack.
Sites wait 3–5 months from visit completion to cash receipt. This is the median across APAC and US-based investigator sites.
For a $100M portfolio, up to $25M sits idle in escrow accounts generating zero research value while studies are ongoing.
Clinical operations finance teams spend a third of their bandwidth resolving payment discrepancies, invoice errors, and reconciliation queries.
Nearly one-third of investigator sites report that payment delays directly threaten their ability to sustain research operations.
Trace how a single completed patient visit takes up to 140 days to translate into a payment at the investigator site — and where value is destroyed at each stage.
Each problem is interconnected. Solving one in isolation fails to address the systemic dysfunction in clinical trial payments.
The sequential, invoice-triggered payment process creates compounding delays at every handoff point. Data lock, invoice generation, CRO reconciliation, sponsor approval, and banking clearance each add weeks. Sites operate in a state of perpetual financial uncertainty, unable to accurately forecast research cash flows.
Sponsors pre-fund large escrow accounts with CROs as a buffer for site payments. These accounts hold 15–25% of the total trial budget in dormant capital. This model compensates for payment process unreliability rather than solving it — effectively using capital as a band-aid for operational dysfunction. At portfolio scale, this represents hundreds of millions in idle capital.
Payment decisions require data from EDC systems, CTMS platforms, budget schedule spreadsheets, CRO financial systems, and site accounting systems — none of which communicate natively. Each reconciliation requires manual data aggregation across disconnected systems, creating error risk, version control issues, and near-zero real-time visibility.
Investigator sites — particularly independent clinics and academic medical centers — operate on thin margins. Delayed payments force sites to cross-subsidize research from clinical revenue, creating operational pressure that drives site dropout, reduces protocol compliance, and erodes the quality of the research infrastructure. An estimated 30% of sites actively consider withdrawing from research due to financial sustainability concerns.
A single site payment requires coherent data from five separate systems, manual reconciliation across three organizational boundaries, and authorization from multiple approval hierarchies.
ClinTrust.ai does not optimize the broken payment process — it replaces it. By forming payables directly from execution data and orchestrating dynamic funding, we eliminate every structural delay in the current model.
See how ClinTrust.ai's execution-aligned payment infrastructure eliminates latency, frees capital, and makes clinical research financially sustainable — for every stakeholder.